PNC Financial Services Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $424K | Buy |
|
|||||
|
2023
Q1 | $372K | Sell |
|
|||||
|
2022
Q4 | $158K | Buy |
|
|||||
|
2022
Q3 | $103K | Sell |
|
|||||
|
2022
Q2 | $124K | Buy |
|
|||||
|
2022
Q1 | $132K | Sell |
|
|||||
|
2021
Q4 | $108K | Sell |
|
|||||
|
2021
Q3 | $1.02M | Sell |
|
|||||
|
2021
Q2 | $1.43M | Sell |
|
|||||
|
2021
Q1 | $1.01M | Sell |
|
|||||
|
2020
Q4 | $1.26M | Buy |
|
|||||
|
2020
Q3 | $990K | Sell |
|
|||||
|
2020
Q2 | $1.73M | Sell |
|
|||||
|
2020
Q1 | $1.64M | Buy |
|
|||||
|
2019
Q4 | $2.26M | Buy |
|
|||||
|
2019
Q3 | $808K | Sell |
|
|||||
|
2019
Q2 | $952K | Hold |
|
|||||
|
2019
Q1 | $862K | Buy |
|
|||||
|
2018
Q4 | $565K | Buy |
|
|||||
|
2018
Q3 | $820K | Hold |
|
|||||
|
2018
Q2 | $352K | Hold |
|
|||||
|
2018
Q1 | $206K | Hold |
|
|||||
|
2017
Q4 | $284K | Buy |
|
|||||
|
2017
Q3 | $312K | Hold |
|
|||||
|
2017
Q2 | $316K | Hold |
|
|||||
|
2017
Q1 | $226K | Hold |
|
|||||
|
2016
Q4 | $218K | Hold |
|
|||||
|
2016
Q3 | $264K | Hold |
|
|||||
|
2016
Q2 | $198K | Buy |
|